HomeInvestors HealthDisc Medicine stock rallies 26% on FDA update for bitopertin (NASDAQ:IRON) Disc Medicine stock rallies 26% on FDA update for bitopertin (NASDAQ:IRON) By BOMAR ENT. November 4, 2024 FacebookTwitterPinterestWhatsApp JHVEPhoto Disc Medicine (NASDAQ:IRON) stock soared 26% Monday after the company said there was a potential to apply for FDA accelerated approval of its drug bitopertin for the treatment of erythropoietic protoporphyria, or EPP, based on existing data. Disc (IRON Source link Previous articleOPTIONS TRADING: A Beginners Crash Course [8 BOOKS in 1] | Including Trading Journal Log Book for Stock Trading and InvestingNext articleToday in history: Financial Insight finance #newspaper #history #history #ai #today latest articles explore more High-Power Audio Amplifier Construction Manual Sports Cards Grading Kit, Card Centering Grading Tool, Sports Trading Cards Measuring Tools. Our Stock Is Rising Why Your Home Insurance Might Not Protect You If Someone Else Lives There How Much Cash Flow Should Your Rentals Make? Fail-Safe Investing: Lifelong Financial Security in 30 Minutes LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
